BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5288508)

  • 1. Hematologic and cytogenetic remission of blastic transformation in chronic granulocytic leukemia.
    Canellos GP; DeVita VT; Whang-Peng J; Carbone PP
    Blood; 1971 Dec; 38(6):671-9. PubMed ID: 5288508
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolonged cytogenetic and hematologic remission of blastic transformation in chronic granulocytic leukemia.
    Canellos GP; Whang-Peng J; Schnipper L; Brown CH
    Cancer; 1972 Jul; 30(1):288-93. PubMed ID: 4504772
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytogenetic remission in acute transformation of chronic granulocytic leukaemia.
    Gibson OM; Burgess MA; Stanley LG
    Br Med J; 1969 May; 2(5656):556. PubMed ID: 5253637
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytogenetic studies during remission of blastic crisis in a patient with chronic myelocytic leukaemia.
    Srodes CH; Hyde EF; Pan SF; Chervenick PA; Boggs DR
    Scand J Haematol; 1973; 10(2):130-5. PubMed ID: 4517256
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of terminal metamorphosis of chronic granulocytic leukaemia with corticosteroids and vincristine.
    Marmont AM; Damasio EE
    Acta Haematol; 1973; 50(1):1-8. PubMed ID: 4200800
    [No Abstract]   [Full Text] [Related]  

  • 6. Heterogeneity of morphological, cytochemical, and cytogenetic features in the blastic phase of chronic granulocytic leukemia.
    Shaw MT; Bottomley RH; Grozea PN; Nordquist RE
    Cancer; 1975 Jan; 35(1):199-207. PubMed ID: 45888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of two Ph1 chromosomes in cells with 49 clone from patient in blast crisis of granulocytic leukaemia.
    Khan MH; Martin H
    Acta Haematol; 1969; 42(6):357-60. PubMed ID: 4986102
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombocytosis in chronic granulocytic leukemia: incidence and clinical significance.
    Mason JE; DeVita VT; Canellos GP
    Blood; 1974 Oct; 44(4):483-7. PubMed ID: 4528824
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy of the blastic phase of chronic granulocytic leukemia: hypodiploidy and response to therapy.
    Canellos GP; DeVita VT; Whang-Peng J; Chabner BA; Schein PS; Young RC
    Blood; 1976 Jun; 47(6):1003-9. PubMed ID: 1064434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome changes in the blastic transformation stage of chronic granulocytic leukaemia.
    Garson OM; de Gruchy GC
    Haematologia (Budap); 1974; 8(1-4):21-7. PubMed ID: 4533487
    [No Abstract]   [Full Text] [Related]  

  • 11. Myelofibrosis in chronic granulocytic leukemia.
    Gralnick HR; Harbor J; Vogel C
    Blood; 1971 Feb; 37(2):152-62. PubMed ID: 5279087
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphoblastic conversion in chronic myelogenous leukemia.
    Crist WM; Ragab AH; Ducos R
    Pediatrics; 1978 Apr; 61(4):560-3. PubMed ID: 78481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of blastic crisis of chronic myeloid leukaemia. Assay of remission induction with vincristine and prednisone in ten cases (author's transl)].
    Feliu E; Nomdedeu B; Bueno J; Grañena A; Nieto LH; Estape J; San Miguel JG; Mundo MR; Rozman C
    Sangre (Barc); 1975; 20(3):243-54. PubMed ID: 1060182
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic granulocytic leukaemia with Ph 1 negative cells in bone marrow and a ten year remission after busulphan hypoplasia.
    Finney R; McDonald GA; Baikie AG; Douglas AS
    Br J Haematol; 1972 Sep; 23(3):283-8. PubMed ID: 4507535
    [No Abstract]   [Full Text] [Related]  

  • 15. Terminal transferase as a predictor of initial responsiveness to vincristine and prednisone in blastic chronic myelogenous leukemia: a co-operative study.
    Marks SM; Baltimore D; McCaffrey R
    N Engl J Med; 1978 Apr; 298(15):812-4. PubMed ID: 273142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour lysis syndrome with hypocälcaemia in accelerated chronic granulocytic leukaemia.
    Cervantes F; Ribera JM; Grañena A; Montserrat E; Rozman C
    Acta Haematol; 1982; 68(2):157-9. PubMed ID: 6812373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic evidence for splenic origin of blastic transformation in chronic myeloid leukaemia.
    Mitelman F; Brandt L; Nilsson PG
    Scand J Haematol; 1974; 13(2):87-92. PubMed ID: 4529166
    [No Abstract]   [Full Text] [Related]  

  • 18. Characteristics of blast crisis in chronic granulocytic leukemia.
    Rosenthal S; Canellos GP; DeVita VT; Gralnick HR
    Blood; 1977 May; 49(5):705-14. PubMed ID: 265737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: The chronic leukemias: current therapeutic concepts.
    Canellos GP; De Vita VT; Schein P; Chabner B; Young RC
    Proc Natl Cancer Conf; 1972; 7():351-7. PubMed ID: 4520052
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination chemotherapy in accelerated phase of chronic granulocytic leukemia.
    Foley HT; Bennett JM; Carbone PP
    Arch Intern Med; 1969 Feb; 123(2):166-70. PubMed ID: 4303268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.